Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-11-22
1995-12-12
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3152
Patent
active
054750024
ABSTRACT:
The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine or of physiologically tolerated salts of this compound for the preparation of pharmaceuticals for the prophylaxis and treatment of nerve damage after interruption of the blood circulation is disclosed.
REFERENCES:
patent: 4289776 (1981-09-01), Mohler et al.
patent: 4719212 (1988-01-01), Goto et al.
J. DeLeo et al., Stroke, 19:1535-1539 (1988).
I. Shinoda et al., Biochemical Pharmacology, 39:1813-1816 (1990).
J. DeLeo et al., Journal of Cerebral Blood Flow and Metabolism, 7:745-751 (1987).
M. Takano et al., Cerebral Vascular Disease, vol. 5 (1985) pp. 327-341.
Danielisova Viera
Grome John
Kolvenbach Ralf
Schneider Ernst J.
Schubert Hans-Peter
Henley III Raymond
Hoechst Aktiengesellschaft
Jarvis William R. A.
LandOfFree
Use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular su does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular su, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular su will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1359942